TCG Crossover Management, LLC: 13F holdings
CIK 18399482026Q2
| Positions | 54 |
|---|
| Reported value | $4.2bn |
|---|
| Filed | 2026-08-14 |
|---|
Change since last quarter
| Positions | 54 (+5 vs prior quarter) |
|---|
| Reported value | $4.2bn (+19.0%) |
|---|
Top 10 holdings
| Security | Shares | Value | Weight |
|---|
| ABVX ABIVAX SA AMERICAN DEPOSITARY SHARES | 6,007,834 | $800.6m | 19.2% |
| TNGX TANGO THERAPEUTICS INC | 9,081,201 | $283.9m | 6.8% |
| CGON CG ONCOLOGY INC | 3,670,206 | $260.8m | 6.3% |
| COGT COGENT BIOSCIENCES INC | 4,854,436 | $187.9m | 4.5% |
| IMVT IMMUNOVANT INC | 4,457,988 | $171.8m | 4.1% |
| SYRE SPYRE THERAPEUTICS INC | 1,900,582 | $168.7m | 4.1% |
| DNTH DIANTHUS THERAPEUTICS INC | 1,676,624 | $163.4m | 3.9% |
| MIRM MIRUM PHARMACEUTICALS INC | 1,062,049 | $124.3m | 3.0% |
| ZLAB ZAI LAB LTD-ADR | 6,137,627 | $116.6m | 2.8% |
| AMLX AMYLYX PHARMACEUTICALS INC | 6,243,812 | $112.1m | 2.7% |
Get the full book
import finzdata as yf
yf.Client().manager_holdings(cik="1839948")
Every position, quarter by quarter since 2013, with adds, trims and exits, on the look-back bundles.
Get a free API keySee history bundlesDownload free samples